Performers / Professionals From Around The Globe

James R Mansfield

PerkinElmer, Inc.
USA

Pooja Saini

The University of Liverpool
UK

Junliang Liu

University of Manitoba
Canada

Hyun Soo Lim

Chungnam National University
South Korea

Jerome Check

Cooper Medical School of Rowan University
USA

Jan Jacques Michiels

Erasmus University Medical Center
Netherlands

Omnia Abd El-Fattah

Tanta University Hospital
Egypt

Giulio Tarro

Foundation de Beaumont Bonelli for Cancer Research
Italy

Kenichiro Hasumi

Hasumi International Research Foundation
Japan

Yuanyuan Chen

University of Hong Kong
China

Saranya Chumsri

Mayo Clinic, Jacksonville
USA

Gia Nemsadze

The Institute of Clinical Oncology
Georgia

Tracks & Key Topics

Tracks

Academic Key Topics

Business Key Topics

ABOUT CONFERENCE

With zeal, we are glad to announce the webinar 6th Edition of International Online Conference on Clinical & Medical Oncology (Oncology 2020) organized in collaboration with generous support and cooperation from enthusiastic academicians and Editorial Board Members. Oncology 2020 aims at sharing new ideas and technologies amongst the professionals, industrialists, and students from research areas of Oncology. As the premier event, we have developed a program with your interests in mind. We have not only increased the number of opportunities for you to network with colleagues from across the world but also introduced more focused sessions that will feature cutting-edge presentations, special panel discussions, and livelier interaction with industry leaders and experts.

Who Should Attend??

Oncology 2020 Conference is a novel discussion to unite overall recognized scholastic Researchers, Public wellbeing experts, Scientists, Academic researchers, Industry specialists, Scholars in the field of Oncology, Haematology, Nursing, Radiology, etc., to exchange about the state of the Research and Development.

Target Audience:

Why Should Attend??

The arranging group assembles eminent speakers covering the most recent advances in the field, fusing differing qualities in each sense. We likewise incorporate talks on the most recent methodologies for concentrating these biological inquiries.

Exclusive B2B meetings, Interactive Sessions, Panel Discussions, Keynote Sessions, Poster Presentations, Oral Presentations, Workshops, Exhibitions, etc., are the main highlights of this event.

Benefits:

All accepted abstracts will be published in the supported Journals and Conference Book Proceeding.
Opportunity to conduct Workshop with your team members
Networking with Keynote Speakers, OCM, and Eminent personalities for the future course of work.
Opportunity to chair a session.
Individual Speaker Page will be created to get more visibility for your scientific research.
Huge Benefits on Group Registration and much more.

Benefits of WEBINARS:

International Speaker Certification
The hard copy of Conference Souvenir, ID card and certificate will be sent to your address
Online publication of the abstract in the conference website
Abstract published in the conference
Proceeding with the unique DOI given
Exclusive Speaker Pages in relation in conference website for all the speakers
Publication discount benefits as a conference attendee
Group Registration discounts
Outstanding Young Researcher Award
Nominations for Best Poster Award
International Networking
Scientific Association, Collaboration, and more..!

Overview of Oncology and Cancer:

Cancer is an abnormal growth of cells that tend to proliferate in an uncontrolled way, and in some cases, to metastasize/spread. Cancer is not a single or one disease but it is a group of different and distinctive diseases. In all types of cancer, some of the body's cells begin to divide without stopping and spread into surrounding tissues, genetically which are called Oncogenes. Cancer can start almost anywhere in the human body, which is made up of trillions of cells. As cancer is spreading in the world very rapidly so many market studies and researches are going on and still so many are under study.

The Innovative idea of Cancer has started great much research to be embraced by the labs around the world. With such an extraordinary number of researchers and scientists taking a shot at Caner research, to date, no significant solution for this is recorded. Clinical Oncology at Frankfurt will manage Cancer Prevention, Diagnosis, and Treatment of illnesses of the Organ-related Cancers and its inventive strategies. Clinical Oncology will also supply the two days of discussions on methods and systems identified with administration and satisfactory exchange of Cancer and in addition to check out the new thoughts and ideas on worldwide scale and the themes include Cancer Developmental Biology, Clinical Oncology And Medical Case Reports, Oncologic Emergencies In Variety Of Subspecialties, Nucleic Acids Damage, Mutation And Cancer, Cell Signalling And Regulation- Neurology , Cancer Immunology And Immunotherapy, Oncolytic Virus And Cancer, Bioscience- Oncology, Paediatric Oncology, Pharmaceutical Oncology And Pharmacokinetic Studies, Gynaecology, Infectious And Oncology, Key Role Of Pathophysiology In Cancer, Oncology Nursing And Care, Radiology And Imaging Current Technologies, Oncology Chemotherapy Advances Research Studies, Cancer: Complementary & Alternative Treatments, Cancer: LifeStyle Connection, Nutrition & Patient Support, Advances In Cancer Research And Treatment, and Overall Future Outcomes And Change In Oncology Practice.

SESSIONS & TRACKS

Track-1: Cancer Developmental Biology

Cell division could be a traditional method utilized by the body for growth and repair. Healthy cells stop dividing once there's not a requirement for additional female offspring cells; however cancer cells still turn out copies. Cancer cells square measure cells that divide unrelentingly, forming solid tumours or flooding the blood with abnormal cells. Cancer biology deals with these changes and also the molecular networks that management cell proliferation, differentiation and death. The study of varied styles of cancer is termed as medical specialty.

Track 1-1Cancer metabolomics

Track 1-2Regenerative cell biology

Track 1-3Host-pathogen interactions

Track 1-4Sarcoma

Track 1-5Renal Cell Carcinoma

Track-2: Clinical Oncology and Medical Case Reports

Clinical oncologists are doctors who treat patients with a balance of radiotherapy and chemotherapy. They are involved in the management of all types of cancer and use a range of other treatments to treat cancers, without using surgery.

They are different than medical oncologists, who use non-radiological treatments for cancer. Clinical oncologists determine which treatment to use by considering a range of factors such as the type of tumour, tumour site, the stage of the disease and the patient’s general health. They assess the relative merits of different treatments before presenting these to the patient.

A case study is a research method involving an up-close, in-depth, and detailed examination of a concerned case (subject/topic), as well as its related contextual conditions. Case studies can be produced by a formal research method followed by an individual, organization, event, or action, existing in a specific time and place. Here we are inviting case studies based on any types of cancer or related incidents or events with facts and figures. Presenting your studies on any other type of cancer in this category will privilege you with a 30% discount on registration.

Track 2-1Cancer Physiology

Track 2-2Identifying Risk Factors

Track 2-3Cancer Biologic Factors

Track-3: Oncologic Emergencies in variety of subspecialties

The 3 major specialties of oncology are:

Medical oncology
Surgical oncology
Radiation oncology

There are several sub-specialties in the field of Oncology. The above mentioned specialties deal with the treatment of cancer through Chemotherapy or Immunotherapy, Biopsies and Radiology respectively.

Track 3-1Neuro-oncology

Track 3-2Ocular oncology

Track 3-3Head & Neck oncology

Track 3-4Thoracic oncology

Track 3-5Breast oncology

Track 3-6Gastrointestinal oncology

Track 3-7Bone & Musculoskeletal oncology

Track 3-8Dermatological oncology

Track 3-9Genitourinary oncology

Track 3-10Adolescent and young adult (AYA) oncology

Track 3-11Hemato oncology

Track 3-12Molecular oncology

Track 3-13Oncopathology

Track 3-14Nuclear medicine oncology

Track 3-15Veterinary oncology

Track 3-16Cardio Oncology

Track 3-17Computational Oncology

Track 3-18Exercises Oncology

Track-4: Nucleic acids damage, Mutation and Cancer

DNA is the repository of genetic information in each living cell, its integrity and stability is essential to life. DNA, however, is not inert; rather, it is a chemical entity subject to assault from the environment, and any resulting damage, if not repaired, will lead to mutation and possibly disease.

Track 4-1DNA damage and repair

Track 4-2RNA

Track 4-3Cancer genetics

Track 4-4Induced Mutagenesis in Cancer

Track 4-5Nuclear and Chromatin Dynamics

Track 4-6SNP- Cancer

Track 4-7Circulating Tumour DNA Analysis

Track-5: Cell signalling and regulation- Neurology

In biology, cell signaling is part of any communication process that governs basic activities of cells and coordinates multiple-cell actions. The ability of cells to perceive and correctly respond to their microenvironment is the basis of development, tissue repair, and immunity, as well as normal tissue homeostasis. Errors in signaling interactions and cellular information processing may cause diseases such as cancer, autoimmunity, and diabetes. By understanding cell signaling, clinicians may treat diseases more effectively and, theoretically, researchers may develop artificial tissues.

All cells receive and respond to signals from their surroundings. This is accomplished by a variety of signal molecules that are secreted or expressed on the surface of one cell and bind to a receptor expressed by the other cells, thereby integrating and coordinating the function of the many individual cells that make up organisms. Each cell is programmed to respond to specific extracellular signal molecules. Extracellular signaling usually entails the following steps:

Synthesis and release of the signaling molecule by the signaling cell.
Transport of the signal to the target cell.
Binding of the signal by a specific receptor leading to its activation.
Initiation of signal-transduction pathways.

Track 5-1Genome integrity

Track 5-2Neurotransmitters

Track 5-3Signal transduction in cancer

Track 5-4Protein dynamics

Track 5-5Cancer: Redox signalling

Track-6: Cancer Immunology and Immunotherapy

Cancer immunology is a stream of immunology that studies communications between the immune system and cancer cells (also called tumors or malignancies). It is a field of research that intent to discover cancer immunotherapies to treat and decelerate evolution of the disease. The human immune system mounts natural endogenous response to foreign cells. The gamut of genetics and epigenetics changes occurring in tumors provides diverse set of antigenic repertoire that host’s immune system can exploit to distinguish tumour versus their normal healthy counterparts.

Track 6-1Cancer Antigens & Vaccines

Track 6-2Host-Tumor Relation

Track 6-3Clinical Cancer immunology

Track 6-4Cellular Immunotherapy

Track 6-5Antibody Therapy

Track-7: Oncolytic Virus And Cancer

An oncolytic virus is a virus that preferentially infects and kills cancer cells. As the infected cancer cells are destroyed by oncolysis, they release new infectious virus particles or virions to help destroy the remaining tumour. Oncolytic viruses are thought not only to cause direct destruction of the tumour cells, but also to stimulate host anti-tumour immune system responses. The potential of viruses as anti-cancer agents was first realised in the early twentieth century, although coordinated research efforts did not begin until the 1960s. A number of viruses including adenovirus, reovirus, measles, herpes simplex, Newcastle disease virus, and vaccinia have been clinically tested as oncolytic agents. Most current oncolytic viruses are engineered for tumour selectivity, although there are naturally occurring examples such as reovirus and the senecavirus, resulting in clinical trials.

Track 7-1Oncolytic behaviour of wild-type viruses

Track 7-2Bio-engineered oncolytic virus for the treatment of cancer

Track 7-3Recently approved therapeutic agents

Track-8: Bioscience- Oncology

Cancer is a genetic disease caused by accumulation of DNA mutations and epigenetic alterations leading to unrestrained cell proliferation and neoplasm formation. The goal of oncogenomics is to identify new oncogenes or tumor suppressor genes that may provide new insights into cancer diagnosis, predicting clinical outcome of cancers and new targets for cancer therapies. The success of targeted cancer therapies such as Gleevec, Herceptin and Avastin raised the hope for oncogenomics to elucidate new targets for cancer treatment. Nanotechnology as defined by size is naturally very broad, including fields of science as diverse as surface science, organic chemistry, molecular biology, semiconductor physics, energy storage, microfabrication, molecular engineering, etc. The associated research and applications are equally diverse, ranging from extensions of conventional device physics to completely new approaches based upon molecular self-assembly, from developing new materials with dimensions on the nanoscale to direct control of matter on the atomic scale.

Track 8-1Cancer Bioinformatics

Track 8-2Cancer Nanotechnology

Track 8-3Cancer Biomarkers

Track 8-4Cancer & Stem cell technologies

Track 8-5Cancer Bio semiotics

Track-9: Paediatric Oncology

Pediatric Oncology is the term used to comprise all malignant conditions among neonates & children with cancer. The most common childhood cancers are, Neuroblastoma, Retinoblastoma, Wilms tumor and brain tumors, such as gliomas. Childhood cancers are very rare and may differ from adult cancers in the way they grow, spread, treated, and respond to treatment.

Track 9-1Clinical Paediatrics

Track 9-2Genetics in Paediatric Oncology

Track 9-3Paediatric Nutrition

Track 9-4Paediatric Radiology

Track 9-5Pediatric Oncology Nursing

Track 9-6Integrative Pediatric Oncology

Track 9-7Palliative Care in Pediatric Oncology

Track-10: Pharmaceutical oncology and Pharmacokinetic studies

A multidisciplinary way to deal with redesign has been connected in a variety of settings in clinical oncology, especially among patients with stomach and colorectal malignancy. Cancer has one of the highest mortality rates of all diseases worldwide. As a pre-treatment prior to hematopoietic progenitor cell transplantation carried out as a part of treatment for all forms of blood cancer, this drug is contributing to patients as a necessary drug that ranks alongside radiation therapy. Hepatitis B antibody was disease counteractive action antibodies upheld Drug Administration (FDA). Disease treatment immunizations were likewise considered restorative antibodies.

Track 10-1Theoretical Medicines

Track 10-2Anti-Metabolite Drugs

Track 10-3Drug interactions

Track 10-4Alkylating Agents

Track 10-5Microtubule Inhibitor

Track 10-6Steroid Hormones

Track-11: Gynaecology, Infectious and oncology

Contaminations in the female genitalia and the extra sex organs are regularly known as Gynecologic InfectiousDiseases. A portion of the irresistible infections is Vulvovaginitis, Cervicitis, Pelvic Inflammatory Diseases, and Sexually Transmitted Diseases. Gynecologic Oncology is a specific field that arrangements with growths relating to the female genitalia and conceptive framework.

Track 11-1Oncology Rehabilitation for Cancer

Track 11-2Gynaecologic and Obstetrics Pathology

Track 11-3Polycystic ovary syndrome

Track 11-4Vulvovaginitis

Track 11-5Cervicitis

Track 11-6Pelvic Inflammatory Diseases

Track 11-7Sexually Transmitted Diseases

Track-12: Key role of pathophysiology in cancer

Pathologists are among the most important members of a patient’s cancer care team. They work to diagnose and determine the stage of cancer, setting the course for what comes next in the treatment journey.Pathology is the service that handles the blood samples and the cells and tissues removed from suspicious ‘lumps and bumps’. Cancer pathology’s key role in diagnosing and treating a complex disease, it’s important to stay up to date on new technologies and breakthroughs that continue to shape the ever-evolving landscape of cancer care.

Track 12-1Cancer Epigenetics

Track 12-2Oncogenomics

Track 12-3Metastasis

Track 12-4Anatomical Pathology

Track 12-5Pathology in cancer diagnostics

Track 12-6Cancer Cytopathology

Track-13: Oncology nursing and care

Oncology Nursing is a field including practice incorporates the jobs of direct guardian, instructor, specialist, head, and scientist. Oncology nursing care can defined as meeting the various needs of oncology patients during the time of their disease including appropriate screenings and other preventative practices, symptom management, care to retain as much normal functioning as possible, and supportive measures upon end of life. Cancer Summit 2019 will make another transformation in malignancy science and disease nursing field.

Track 13-1Nutritional care

Track 13-2Supportive Care

Track 13-3Management & Palliative Care

Track 13-4Assessing Physical & Emotional Status

Track 13-5Treatment Plans

Track 13-6Symptom Management

Track 13-7Direct Patient Care

Track-14: Radiology And Imaging current Technologies

Radiology is the medical discipline that uses medical imaging to diagnose and treat diseases within the bodies of both humans and animals. A variety of imaging techniques such as X-ray radiography, ultrasound, computed tomography (CT), nuclear medicine including positron emission tomography (PET), and magnetic resonance imaging (MRI) are used to diagnose or treat diseases. Interventional radiology is the performance of usually minimally invasive medical procedures with the guidance of imaging technologies such as those mentioned above.

Track 14-1Cancer Biopsy

Track 14-2Cancer Histopathology

Track 14-3Cancer Differentiation

Track 14-4Computational Oncology

Track-15: Oncology Chemotherapy Advances Research studies

Cancer cells keep growing without control. Chemotherapy is drug therapy for cancer. It works by killing the cancer cells, stopping them from spreading, or slowing their growth. However, it can also harm healthy cells, which causes side effects. Cancer can be treated by surgery, chemotherapy, radiation therapy, hormonal therapy, targeted therapy and synthetic lethality.

Track 15-1Cancer Radiation Therapy

Track 15-2Cancer Targeted therapy

Track 15-3Cell-based therapy

Track 15-4Hormonal therapy

Track 15-5Cancer Curative treatment

Track 15-6Cancer Palliative treatment

Track 15-7Limitations of Chemotherapy

Track 15-8Cancer Therapeutics, Novel and experimental approaches

Track 15-9Adverse effects of chemotherapy

Track-16: Cancer: Complementary & alternative treatments

Complementary and alternative are terms used to describe many kinds of products, practices, and systems that are not part of mainstream medicine. You may hear them used to refer to methods to help relieve symptoms and improve quality of life during cancer treatment. We call these “complementary” because they are used along with your medical treatment.

Track 16-1Aromatherapy

Track 16-2Ayurveda

Track 16-3Art & Music Therapy

Track 16-4Homeopathic Medicines

Track 16-5Anti-Cancer Agents in Medicinal Chemistry

Track-17: Cancer: Life style Connection, nutrition & Patient Support

Many factors impact the development of cancer. Over the last 25 years, science has displayed that diet,body weight and physical activity —especially being overweight or obese—are leading risk factors for obtaining certain types of cancer. The main behavioral and environmental risk factors for cancer death in the world are related to diet and physical inactivity, use of addictive substances, sexual and reproductive health and exposure to air pollution and use of contaminated needles.

Track 17-1Investigation into Cancer and Nutrition (EPIC)

Track 17-2Lifestyle Factors

Track 17-3Population Attributable Risks

Track-18: Advances In Cancer Research And Treatment

Instruments are designed to aid in the diagnosis, monitoring or treatment of medical conditions. Several new types of equipment are used in the treatment of cancer such as:

Linear Accelerator (LINAC) – It emits radiation of highly localised (X-rays) and it is useful in the treatment of cancer. The 6 MeV linear accelerator having the capability of surface electron allows treating cancer cells even under the subcutis layer overlying the cranium. The patient can also see his activity through the connected display unit.

Gamma Camera – It is used in the detection of cancer via gamma rays. Here tracers used are introduced into the patient’s body intravenously, thus getting the image on the gamma camera as the tracer emits gamma rays which are detected by the gamma camera.

Radiography and Ultrasound – It is a non-invasive way of getting the image of the internal organs by ultrasound. It is a useful method for cancer patients for examining the abdomen for any enlargement of the lymph or masses.

Track 18-1Targeting the DNA Damage Response to Generate New Cancer Therapies

Track 18-2Preclinical & Clinical Research

Track 18-3Early Detection Research

Track 18-4Immunoprevention

Track-19: Overall Future Outcomes and Change in Oncology Practice

Leukemia, Lymphoma, Germ cell tumors and early stage solid tumors which were once incurable have become curable malignancies now. Immunotherapies have already proven efficient in leukemia, bladder cancer and various skin cancer. For the future, research is promising in the field of physical oncology. Survival of cancer has significantly improved over the past years due to improved screening, diagnostic methods and treatment options with targeted therapy. Large multi-centric Phase III randomised controlled clinical trials by the National Surgical Adjuvant Breast & Bowel Project (NSABP), Medical Research Council (MRC), the European Organisation for Research and Treatment of Cancer (EORTC) and National Cancer Institute (NCI) have contributed significantly to the improvement in survival.

MARKET ANALYSIS

Cancer is a disease characterized by uncontrolled cell proliferation. There are more than 100 types of cancer. The most common causes of cancer death are cancers of Lung (1.69 million deaths), Liver (788 000 deaths), Colorectal (774 000 deaths), Stomach (754 000 deaths) and Breast (571 000 deaths) which accounts for nearly half of new cases per year. Lung cancer, which is highly correlated with cigarette smoking, is responsible for more deaths than any other form of cancer. Cigarette smoking and other environmental factors are associated with the majority of cancers.

The kinds of cancer we expect to increase the most are

Melanoma (the deadliest kind of skin cancer) in white men and women.
Prostate, kidney, liver, and bladder cancers in men.
Lung, breast, uterine, and thyroid cancers in women.

Cancer is among the leading causes of death worldwide. In 2012, there were 14.1 million new cases and 8.2 million cancer-related deaths worldwide. The number of new cancer cases per year is expected to rise to 23.6 million by 2030. The most recent SEER Cancer Statistics Review, released in April 2019, shows that cancer death rates decreased by 1.8% per year among men from 2006 to 2015, 1.4% per year among women from 2006 to 2015 and 1.4% per year among children ages 0–19 from 2011 to 2015.

Global Oncology/Cancer drugs Market is expected to garner $111,938.4 million by 2020, registering a CAGR of 7.1% during the forecast period 2014 to 2020. Recent progress in biological therapies has widened the scale of therapeutic targets for cancer treatment with the identification of tumour cell specific genes. The number of approved cancer therapies continues to rise. The continued rise and impact of immuno-oncology has been largely centred on the PD-1 and PD-L1 checkpoint inhibitors, which have broad efficacy across solid tumours and are used across 23 different tumour types. Overall, the global market for oncology therapeutic medicines will reach as much as $200 billion by 2022, averaging 10—13% growth over the next five years, with the U.S. market reaching as much as $100 billion by 2022, averaging 12–15% growth.

Breakthrough advancements in the development of genetic-based tests for oncology and other disorders during the past few years have significantly propelled market growth. Next generation sequencing technology offers a better understanding of tumor mechanism, thus enabling rational drug design. As a result, more products are expected to get commercialized in the near future.

A rise in oncology-related spending is further expected to fuel market growth in the coming years. Government organizations are focused on encouraging patients to regularly undergo diagnostic examinations to reduce oncology-related healthcare expenditures. As per data estimates, healthcare expenditure is anticipated to rise significantly, thereby influencing the adoption of NGS diagnostics platforms.

The biotechnology industry is marked by high competition and so is the NGS market for clinical as well as research applications. Prominent participants are actively involved in R&D to develop novel rapid, small, and less expensive platforms. Service providers are embracing the trend of increasing the amount of constructed sequence reads for each cycle run.

Commercially available sequencing platforms analyze both DNA and RNA samples. Key players aim to increase the utility of high throughput technologies for clinical applications. The acquisition of smaller entities operating in the market is also one of the strategic initiatives adopted by players to maintain a competitive position. For instance, in May 2018, Illumina acquired Edico Genome to accelerate data analysis for its next generation sequencing platforms.

LEARN MORE

The age-standardised rate for all cancers (including non-melanoma skin cancer) for men and women combined was 197.9 per 100,000 in 2018. The rate was higher for men (218.6 per 100,000) than women (182.6 per 100,000).

With the burden growing in almost every country, prevention of cancer is one of the most significant public health challenges of the 21st century. Around 40% of cancer cases could be prevented by reducing exposure to cancer risk factors including diet, nutrition and physical activity – for more information see our Cancer Prevention Recommendations or read our blog.

Reducing the cancer burden requires concerted and integrated action from all sectors of society, including civil society, private sector, and health and other professions. You can read what policy actions different countries are taking to promote healthier diets in our NOURISHING framework and accompanying database.

Age-standardised rates are used in the tables. This is a summary measure of the rate of disease that a population would have if it had a standard age structure. Standardisation is necessary when comparing populations that differ with respect to age because age has a powerful influence on the risk of dying from cancer.

The highest cancer rate for men and women together was in Australia, at 468.0 people per 100,000.
The age-standardised rate was at least 320 per 100,000 for 12 countries: Australia, New Zealand, Ireland, Hungary, the US, Belgium, France (metropolitan), Denmark, Norway, the Netherlands, Canada and New Caledonia (France).
The countries in the top 12 come from Oceania, Europe and North America.

Cancer associations all over the world:

AIM at Melanoma
American Brain Tumor Association
American Cancer Society
American Childhood Cancer Organization
American Council on Life Insurers
American Dietetic Association
American Hospice Foundation
American Lung Association
American Pain Foundation
American Psychosocial Oncology Society
American Society of Clinical Oncology
Angel Flight America
Association of Oncology Social Work
Bladder Cancer Advocacy Network
Bone Marrow & Cancer Foundation
BreastCancer.org
Bright Pink
Cancer Care
Cancer and Careers
Cancer
Cancer Hope Network
Cancer Legal Resource Center
Cancer Research and Prevention Foundation
CaringBridge.org
CarePages
Caring Info
Centers for Disease Control and Prevention Cancer Information
Centers for Medicare and Medicaid Services
Center for Mind-Body Medicine
Children’s Cause for Cancer Advocacy
Chronic Disease Fund
Center for Cancer Research
Clinical Trials
Colon Cancer Alliance
Co-Pay Relief Program
Corporate Angel Network
CoverageForALL
Crush It For Curtis Foundation
Emergingmed
Facing Our Risk of Cancer EMPOWERED (FORCE)
Family Caregiver Alliance
Family Reach
Feeding America
Fight Colorectal Cancer
Head and Neck Cancer Alliance (HNCA)
Health Resources and Services Administration
HealthWell Foundation
Imaginary Friend Society
Inflammatory Breast Cancer Research Foundation
Intercultural Cancer Council
International Myeloma Foundation
International Waldenstrom’s Macroglobulinemia Foundation
Joe’s House
Kidney Cancer Association
Leukemia and Lymphoma Society
Living Beyond Breast Cancer
Lung Cancer Alliance
LUNG evity Foundation
Lymphoma Research Foundation
Melanoma Research Foundation
Men Against Breast Cancer
MetaCancer Foundation, Inc.
Multiple Myeloma Research Foundation
Mylifeline.org
National Brain Tumor Society
National Breast Cancer Coalition
National Cancer Institute
National Center for Complementary and Alternative Medicine
National Cervical Cancer Coalition
National Children’s Cancer Society
National Coalition for Cancer Survivorship
National Energy Assistance Referral
National Hospice and Palliative Care Organization
National Lymphedema Network
National Marrow Donor Program
National Organization for Rare Disorders
National Ovarian Cancer Coalition
National Patient Travel Center
Native American Cancer Research
NeedyMeds
Nueva Vida
Office of Minority Health
Oncolink
Oncology Nursing Society
Oral Cancer Foundation
Ovarian Cancer National Alliance
Pancreatic Cancer Action Network
Partnership for Prescription Assistance
Patient Access Network Foundation
Patient Advocate Foundation
Patient Services, Inc. (PSI)
Prostate Cancer Foundation
The Prostate Net
Rosalynn Carter Institute for Caregiving
Sisters Network
Skin Cancer Foundation
Social Security Administration
State Health Insurance Assistance Programs (SHIP)
Survivorship A to Z
Support for People with Oral and Head and Neck Cancer (SPOHNC)
Susan G. Komen Breast Cancer Foundation
Thyroid Cancer Survivor’s Association
Together Rx Access
The Ulman Cancer Fund for Young Adults
United Way
Uniting Against Lung Cancer
US TOO International Prostate Cancer Education & Support Network
Vital Options International
WomanLab
Young Survival Coalition
Zero - The Project to End Prostate Cancer

List of Cancer Hospitals all over the world:

Alvin J. Siteman Cancer Center
Antoni van Leeuwenhoekziekenhuis
Cancer Institute Hospital of JFCR
City of Hope National Medical Center
Cross Cancer Institute
Dharamshila Cancer Hospital and Research Centre
Docrates Cancer Center
Dr. B. Borooah Cancer Institute
Finsen Laboratory
Fox Chase Cancer Center
Fuda Cancer Hospital-Guangzhou
Homi Bhabha Cancer Hospital & Research Centre
Huntsman Cancer Institute
Institute of Cancer of São Paulo
Integris Cancer Institute
The James Cancer Hospital
John Stoddard Cancer Center
Kanagawa Cancer Center
Kidwai Memorial Institute of Oncology
King Hussein Cancer Center
Mahavir Cancer Institute and Research Centre
Malabar Cancer Centre
Mary Bird Perkins Cancer Center
Memorial Sloan Kettering Cancer Center
H. Lee Moffitt Cancer Center & Research Institute
National Institute of Cancer Research and Hospital
New York Cancer Hospital
Oncocare
Peter MacCallum Cancer Centre
Princess Margaret Cancer Centre
Radiumhemmet
Rajiv Gandhi Cancer Institute and Research Centre
Reno CyberKnife
Royal Marsden Hospital Seton Healthcare Family
Shanghai Cancer Center
Sun Yat-sen University Cancer Center
Tata Memorial Centre
Tom Baker Cancer Centre
UCSF Bakar Cancer Hospital
UCSF Helen Diller Family Comprehensive Cancer Center
University of Florida Cancer Hospital
University of Michigan Rogel Cancer Center
University of Texas MD Anderson Cancer Center
Vattikuti Urology Institute
Velindre Cancer Centre
Victorian Comprehensive Cancer Centre
Winship Cancer Institute
Zhejiang Cancer Hospital

No. of deaths caused by cancer, World 2019 statistics:

Cancer is a generic term for a large group of diseases that can affect any part of the body. Other terms used are malignant tumours and neoplasms. One defining feature of cancer is the rapid creation of abnormal cells that grow beyond their usual boundaries, and which can then invade adjoining parts of the body and spread to other organs, the latter process is referred to as metastasizing. Metastases are a major cause of death from cancer.

Cancer is the second leading cause of death globally, and is responsible for an estimated 9.6 million deaths in 2018. Globally, about 1 in 6 deaths is due to cancer.
Approximately 70% of deaths from cancer occur in low- and middle-income countries.
Around one third of deaths from cancer are due to the 5 leading behavioural and dietary risks: high body mass index, low fruit and vegetable intake, lack of physical activity, tobacco use, and alcohol use.
Tobacco use is the most important risk factor for cancer and is responsible for approximately 22% of cancer deaths.
Cancer causing infections, such as hepatitis and human papilloma virus (HPV), are responsible for up to 25% of cancer cases in low- and middle-income countries.
Late-stage presentation and inaccessible diagnosis and treatment are common. In 2017, only 26% of low-income countries reported having pathology services generally available in the public sector. More than 90% of high-income countries reported treatment services are available compared to less than 30% of low-income countries.
The economic impact of cancer is significant and is increasing. The total annual economic cost of cancer in 2010 was estimated at approximately US$ 1.16 trillion.
Only 1 in 5 low- and middle-income countries have the necessary data to drive cancer policy.